Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:05:23 UTC, with 10 holding rows worth $323,634,131.

Accession
0001012975-26-001061
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 10 entries on the cover page, a total value of $323,634,131 stated on the cover page (in dollars after the unit check, H1), rows summing to $323,634,131 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vanguard FTSE All-World ex-US ETF922042775SHS3,243,484$269,111,867dollars as filed
ISHARES TR46429B598MSCI INDIA ETF369,600$17,252,928dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM989,410$13,327,353dollars as filed
TEAMSHARES INC87821B109COM1,099,974$7,991,311dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,573,761$5,618,327dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,627,643$4,388,164dollars as filed
SURROZEN INC86889P208COMMON STOCK87,696$2,822,057dollars as filed
ALECTOR INC014442107COMMON STOCK1,307,858$2,419,537dollars as filed
TENAYA THERAPEUTICS INC87990A106COM1,015,705$613,080dollars as filed
MERLIN INC590106100COM47,610$89,507dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-26-001061this filing2026-11-16